The education library
Steroid education in Canada: reading the evidence
Educational information, not personal medical advice. AI-assisted research and editorial preparation by AnabolicRX. Sources checked 23 October 2026. No independent clinical review has been completed. This library is associated with a supplies store; it does not sell steroids or provide instructions for nonmedical use.
What is known about health risks?
Health Canada identifies cardiovascular, liver, reproductive, skin and mood risks associated with anabolic steroids in bodybuilding products. These are class-level concerns, not a measured risk estimate for every individual compound. Health Canada
A 2025 Danish registry cohort compared 1,189 men sanctioned for anabolic-steroid use with 59,450 matched controls over an average of 11 years. Several cardiovascular outcomes were more frequent in the exposed group. The adjusted hazard ratio for myocardial infarction was 3.00, with a 95% confidence interval of 1.67–5.39. This is a relative association, not a 3% risk or proof that every steroid has that effect. Selection into an antidoping programme, residual confounding and mixed exposures limit generalization. These results must not be equated with a trial of prescribed testosterone replacement. Primary cohort abstract
Does Schedule IV mean a product is authorized?
No. Controlled-substance classification and authorization of a particular drug product are separate issues. Canada's Schedule IV covers anabolic steroids and their derivatives. Health Canada's Drug Product Database is the relevant starting point for product records; a brand name or foreign label alone does not establish Canadian authorization. No blanket legal conclusion about a person's circumstances is made here. Canadian schedule Drug Product Database
Why do studies disagree?
Study population, formulation, comparison treatment and outcome matter. A bone-density change is not proof of fewer fractures. A veterinary experiment is not a human trial. A small case series can describe a safety signal without measuring its frequency. A randomized parent study does not make every secondary treatment comparison randomized. Each profile identifies these distinctions where relevant.
How this library is prepared
Articles are AI-assisted educational summaries based on linked regulator documents and primary research. Reference-site pages were used to identify topics, not copied as medical evidence. Citation-only records are marked as leads. No clinician has reviewed or endorsed these articles. The research date indicates when sources were checked, not when a medical review occurred.
The library is associated with a supplies store. That commercial context must remain disclosed, and does not justify promotional health claims. The profiles contain no steroid purchasing links or nonmedical administration protocols. Editorial responsibility rests with AnabolicRX. To flag a factual error, email [email protected] with the page title, the specific claim and a supporting source. Do not send personal medical information. Independent clinical review has not been completed.
What these profiles do not answer
They do not provide individualized treatment, dosing, combinations, sourcing or self-managed recovery instructions. Missing evidence is not evidence of safety. Questions about actual symptoms, fertility or prescribed medicines belong with a qualified healthcare professional.